Bibiografie finala

download Bibiografie finala

of 5

Transcript of Bibiografie finala

  • 8/20/2019 Bibiografie finala

    1/9

     Teste de autoevaluare r\spunsuri corecte

    - 438 - 

    Teste de autoevaluare: r\spunsuri corecte

    1. d2. a3. c4. b5. e6. e

    7. d8. a9. c10. c11. b12. d13. d14. b15. d16. d17. a18. d19. d20. c21. aeg22. bce23. abdf24. ade25. cdf26. ab27. cf28. bd29. bcd30. de31. a32. b33. d

    34. e35. a36. a37. a38. d39. c40. b41. c42. a43. c

    44. c45. c46. c47. c48. c49. a

    50. c51. 1d 2c 3a 4b52. 1e 2c 3a 4d 5b53. a4 b3 c1 d2 e554. a55. b56. d57. b58. a59. c60. e61. c62. d63. a64. d65. e66. c67. a68. b69. c70. a71. e72. d73. b74. c75. c76. d

    77. b78. d79. c80. d81. b82. b83. c84. c85. c86. b

    87. f88. b89. a90. e91. b92. a

    93. a94. e95. d96. ac97. abc98. abc99. abd100. cd101. de102. af103. abe104. bce105. acde106. c107. c108. b109. a110. c111. c112. c113. c114. b115. d116. a117. c118. a119. b

    120. c121. a122. e123. c124. e125. c126. e127. c128. d129. d

  • 8/20/2019 Bibiografie finala

    2/9

     Teste de autoevaluare r\spunsuri corecte

    - 439 - 

    130. c131. e132. d133. a134. 1b 2c 3a 4d135. a=2,4 b=1,3136. a2 b1137. a=2,3 b=1,4138. a2 b3 c1139. a1 b2140. 1c 2e 3b 4a 5d141. c142. c143. a144. a145. a146. e147. a148. b149. e150. e151. e152. b153. a154. b155.

    b156. e157. c158. c159. c160. e161. e162. a163. c164. a165. b166. b167. e168. a169. c170. e171. e172. a173. d174. c175. e176. d177. c178. a

    179. c180. e181. b182. b183. e184. c185. c186. c187. a188. c189. d190. d191. c192. b193. c194. c195. c196. c197. c198. b199. c200. b201. b202. c203. c204.

    bdf205. bd206. abde207. ac208. bce209. abcde210. abcef211. abc212. abcef213. abcd214. 1c 2b 3c 4d215. 1c 2c 3d 4d 5b216. 1a 2b 3c 4d 5e

    6f217. 1a 2b 3c218. b219. e220. c221. e222. c223. a224. a225. a226. b

    227. b228. a229. d230. e231. d232. a233. e234. c235. b236. b237. d238. c239. ade240. abcde241. abd242. abc243. abc244. abc245. abcd246. abcef247. abf248. ab249. abce250. abcd251. e252.

    c253. e254. c255. d256. d257. d258. 1a 2b259. 1b 2a260. 1ab 2cd261. 1e 2c 3b 4a 5d262. 1c 2a 3b 4e 5d263. 1b 2e 3d 4c 5a264. 1abc 2d265. b266. a267. e268. e269. a270. c271. b272. b273. a274. b275. b

  • 8/20/2019 Bibiografie finala

    3/9

     Teste de autoevaluare r\spunsuri corecte

    - 440 - 

    276. b277. d278. d279. e280. d281. c282. b283. b284. d285. e286. c287. e288. e289. d290. e291. b292. c293. c294. e295. ac296. abce297. ac298. ade299. bd300. abc301.

    bc302. abc303. e304. c305. c306. d307. d308. d309. 1d 2c 3a 4e 5b310. 1e 2b 3a 4c 5d311. a3 b1 c2312. 1c 2a 3b313. 1d 2a 3c 4e 5b314. b315. b316. e317. b318. b319. b

    320. e321. b322. b323. d324. e325. d326. b327. c328. e329. b330. e331. a332. a333. a334. e335. c336. a337. abcd338. abcd339. abcde340. abc341. 1e 2d 3c 4b 5a342. 1i 2h 3g 4f 5e 6d

    7c 8b 9a343. d344.

    d345. e346. d347. d348. e349. b350. b351. d352. c353. b354. b355. c356. a357. b358. b359. b360. b361. a362. b

    363. c364. a365. d366. c367. b368. e369. e370. b371. c372. e373. c374. d375. a376. a377. a378. d379. a380. b381. c382. a383. cd384. ac385. abcd386. bd387. ae388.

    1d 2a 3e 4b 5c389. 1e 2c 3a 4d 5b390. 1b 2e 3d 4c 5a391. 1c 2d 3b 4a 5e392. 1a 2e 3d 4c 5b393. c394. d395. b396. a397. c398. a399. a400. b401. c402. c403. a404. a405. e

  • 8/20/2019 Bibiografie finala

    4/9

     Bibliografie

    - 441 - 

    BIBLIOGRAFIE SELECTIV|

    1. Alderman MH, Ooi WL, Chen H et al. – Plasma renin activity: a riskfactor for myocardial infarction in hypertensive patients. Am. J.Hipertens. 1997; 10: 1 – 8.

    2. Al-Obaidi K.M., Philippou H., Stubbs J.P. et al.: Relationships betweenhomocysteine, factor VIIa and thrombin generation in acute coronarysyndromes. Circulation, 2000; 101, 372 – 377.

    3. Anand – Srivastava BM:  Atrial natriuretic peptide – C receptor andmembrane signalling in hypertension. J. of Hypertension, 1997; 15: 815 – 825.

    4. Appel G.B.: The nephrotic syndrome. In Cecil Textbook of Medicine,20-th edition, Bennett and Plum, 1996; 1; 573-579.

    5. Bancks P.: Acute pancreatitis. In Feldman M. eds.: Sleisenger andFordtran’s Gastrointestinal and Liver Disease, 6th ed., London, 1998;809-838.

    6. Barbu R, Nedelcu I., Rinichiul, fiziopatologie clinic ă, Ed.Medicală,Bucureşti, 1988.

    7. Baron J. H: Peptic ulcer: a problem almost solved . Journal of RoyalCollege of Physicians of London, 1997; 31; 512 – 518.

    8. Baron J.H:  An assessment of the augmented histamine test in thediagnosis of peptic ulcer . Gut, 1993; 4; 243 – 53.

    9. Baron J.H: The discovery of acid inhibition. Yale J. Biol Med, 1994; 24;21 – 36.

    10. Becker FH, Piper JA, Flynn EW: Breathing during sleep in patients withnocturnal desaturation. Am. J. Respir. Crit care Med, 1999; 159; 112-118.

    11. Berceanu Şt., Hematologie clinic ă, Ed. Medicală, 1977.

    12. Blei A.T.: Portal hypertension. Curr. Opin. Gastroenterol.,1996; 10;

    295-302.13. Bousquet J., Chancz P., Lacoste J.Y. et al. Eosinophilic inflammation

    in astm. N. Engl. J. Med., 1990; 323: 1033 – 9.

    14. Brady H.R. et al.: The major glomerulopathies. In Harrison’s Principlesof Internal Medicine, fourteenth edition, Mc Graw-Hill Company, 1998;2; 1536-1545.

  • 8/20/2019 Bibiografie finala

    5/9

     Bibliografie

    - 442 - 

    15. Braun J.  Ghid clinic de Medicină  Internă  – explor ări, diagnostic,terapie, urgenţ e, ed.a 5-a, Ed. Medicală, 1997.

    16. Bravo EL: Envolving concepts in the pathophysiology, diagnosis andtreatment of pheochromocytoma. Endocrinol. Rev. 1994; 15: 356 –368.

    17. Brian J.W: Dynamics of pulmonary gas exchange. Circulation (suppl,1987; 76; VI – 18 – 27.

    18. Buja LM, Willerson JT: Role of inflammation on coronary plaquedisruption. Circulation, 1994; 89, 503 – 505.

    19. Calam J., Gibbons A. et al.: How does Helicobacter pylori causemucosal damage? It’s effect on acid and gastric physiopathology.Gastroenterology, 1997; 113; S43-S49.

    20. Cohen – Solal A: Role of aldosteron in heart failure; Eur Heart J., 2000;2 (Suppl. A); A 17 – A 20.

    21. Cohn N J: From hypertension to heart failure  – Eur. Heart J.Supplements, 2000, 2: A2 – A5.

    22. Colucci SW, Braunwald E: Pathophysiology of heart failure; HeartDisease, WB saunders, Philadelphia, 1999; 364 – 74.

    23. Covic M., Ungureanu G.: Insuficienţa renală  acută. În TerapeuticaMedicală, Polirom, Iaşi, 2000; 438.

    24. Covic Mircea, Covic A. Boala polichistic ă renal ă autosomal dominant ă (ADPKD), Ed. Polirom, Iaşi, 1999.

    25. Cucuianu M., Crâsnic I., Pleşca – Manea L.: Biochimie clinic ă.Fundamentare fiziopatologic ă. Ed. Dacia, Cluj – Napoca, 1998.

    26. Davey P, Meyer T, Coats A et al: Ventilation in chronic heart failure:effects of physical training . Br Heart J, 1992; 68; 473 – 7.

    27. Davies PF: Flow – mediated endothelial mechanotransduction. PhysiolRev, 1995; 75; 519 – 560.

    28. Dean C.N, Brown K.J, Himelman B.R et al: Oxygen may improvedyspnea and endurance in patients with chronic obstructive pulmonary

    disease and only mild hypoxemia. Am Rev Resp Dis, 1992; 146; 941 –945.

    29. Dumitraşcu D., Patologia digestiv ă func ţ ional ă, Ed.Medicală, Bucureşti,1991.

    30. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation,1995, 92, 657 – 671.

  • 8/20/2019 Bibiografie finala

    6/9

     Bibliografie

    - 443 - 

    31. Ferrari R, Bachetti T, Agnoletti L,Comini L, Curello S: Endothelialfunction and dysfunction in heart failure; Eur Heart J, 1998; 19 (Suppl.G); G 41 – G 47.

    32. Gallagher GC: Exercise and chronic obstructive pulmonary disease. Med Clinics of North Am, 1990; 74; 619 – 639.

    33. Gherasim L, Apetrei E.  Actualit ăţ i în cardiologie, Ed.Medicală  AMALTEA, 1998.

    34. Gherasim L: Medicina internă, vol. III: Bolile digestive, hepatice şipancreatice. Ed. Medicală, Bucureşti, 1999.

    35. Gherman- Căprioar ă M., Patiu I.M. et al.: Insuficienţa renală acută. ÎnNefrologie clinică, sub red N. Ursea, Bucureşti, Fundaţia Română  aRinichiului, 2001; 507-534.

    36. Gimbrone AM: Vascular endothelium hemodynamic forces andatherogenesis. Am J Cardiol of pathology, 1999; 155; 1 – 5.

    37. Gligor E, Predescu D, Vulcu R, Vultur A, Zdrenghea D: Disfunc ţ iaendotelial ă  în patogeneza cardiopatiei ischemice. AMT, 1997; 3 –4 ,119 – 123.

    38. Gligor E, Vultur A, Ilea M, Predescu D et al: Rigiditatea arterial ă  la pacienţ ii cu angină  pectoral ă  stabil ă  şi potenţ iale ventriculare tardive prezente. În “Revista Română de Cardiologie”, (Supl. I), 1998; 8; 99 –103.

    39. Gligor E.: Fiziopatologie II (Marile sisteme func ţ ionale), Ed. Casa căr ţiide ştiinţă, Cluj, 2000.

    40. Goggins M., Kelleher D.: Celiac disease and other nutrient relatedinjuries to the gastrointestinal tract. Am. J. Gastroenterol., 1994; 89;S1-S17.

    41. Graham D.Y, Go M.F: Helicobacter pylori: current status. Gastroenterology, 1993; 105; 279 – 282.

    42. Guyton A.C.Fiziologie ediţia a 5-a, 1997

    43. Halliwell B:  Antioxidants in human health and disease. Ann Rev Nutr,1996; 16; 33 – 50.

    44. Harrap SB: Hypertension: gene versus environment . Lancet, 1994;344: 169 – 171.

    45. Harris RC: The macula densa: recent developments.  J. Hypertens.1996; 14: 815 – 822.

    46. Haulica I: Fiziologie umană, Ed. Med.Bucureşti, 1997, pp. 473-500.

    47. Joven J. e al.: Abnormalities of lipoprotein metabolism in patient withthe nephrotic syndrome. N. Engl. J. Med., 1990; 323; 579-584.

  • 8/20/2019 Bibiografie finala

    7/9

     Bibliografie

    - 444 - 

    48. Kagnoff M.F.: Immunology and inflamation of the gastrointestinal tract.In Feldman M. eds.: Sleisenger and Fordtran’s Gastrointestinal andLiver Disease, 6th ed., London, 1998; 19-48.

    49. Kaplan MN: Clinical Hypertension. Williams & Wilkins, 1998, Baltimore.

    50. Karmazyn M: Expression and role of NHE in myocardial injury ; Eur.Heart J. (Suppl.K), 1999; 1; K 40 – K 43.

    51. Katz DS: Mechanisms and implications of endothelial dysfunction incongestive heart failure. Current Opinion in Cardiology, 1997; 12; 259 –264.

    52. Keith M, Geranmayegan A, Sole JM: Increased oxidative stress in patients with congestive heart failure. J Am c Cardiol, 1998; 1; 1352 –1356.

    53. Kugiyama K, Yasue H, Okumura K, Ogava H, Fujimoto K: Nitric oxideactivity is deficient in spasm arteries of patients with coronary spasticangina. Circulation, 1996; 94, 267 – 272.

    54. Kumar, Kotran, Robbins: Basic Pathology, sixth edition, 1997

    55. Lloys L.M., Olsen A.V.: Disorders of the epithelial transport in the smallintestin. In Yamada T. ed.: Textbook of Gastroenterology, secondedition, J.P. Lippincott Co., Philadelphia, 1995; 661-672.

    56. Luster D.A. Chemokines – chemotactic cytokines that mediate

    inflammation. The N. Engl. J. of Med., 1998; 338: 436 – 444.57. Malek AM, Izumo S: Molecular aspects of signal transduction of shear

    stress in the endothelial cell . J Hypertension, 1994; 12; 989 – 999.

    58. Marlfertheiner P, Ditschuneit H: Helicobacter pylori, gastritis and pepticulcer . Berlin; Springer – Verlag, 1990.

    59. Marsh N.M., Riley A.S.: Digestion and absorption of nutrients andvitamins. In Feldman M. eds.: Sleisenger and Fordtran’sGastrointestinal and Liver Disease, 6th ed., London, 1998; 1471-1500.

    60. Mitch E.W.: Acute renal failure. In Cecil Textbook of Medicine, ed. a21-a, Philadelphia, Saunders, 2000; 567.

    61. Mittmann C, Eschenhagen T, Scholz H: Cellular and molecular aspectsof contractile dysfunction in heart failure. Cardiovascular Research,1998; 39; 267 – 275.

    62. Miu N: Hepatitele cronice ale copilului . Casa căr ţii de ştiinţă, 1999.

    63. Miyaki H., Ito S. et al.: Hyperamonemia and Helicobacter pylori.Gastroenterology, 1997; 112; A-R22.

    64. Mungiu Ostin C., Paveliu Fraga, Paveliu S., Farmacologie biochimic ă –o abordare terapeutic ă, Ed.Infomedica, 2000.

  • 8/20/2019 Bibiografie finala

    8/9

     Bibliografie

    - 445 - 

    65. Negoiţă C. Clinic ă Medical ă, vol.I şi Vol.II, Ed. Didactică şi pedagogică,Bucureşti, 1995.

    66. Nor EJ, Christensen J, Mooney JD et al.: Vascular endothelial growthfactor (VEGF) – Mediated angiogenesis is associated with enhancedendothelial cell survival and induction of Bcl – 2 expression;  J. ofPhatology, 1999; 154; 375 – 385.

    67. O’Donnell ED, McGuire M, Samis L et al: General exercise trainingimproves ventilatory and peripheral muscle stregth and endurance inchronic airflow limitation. Am. J. Respir. Crit Care Med, 1998;157; 1489 – 1497.

    68. Olinescu A. Imunologie. Ed. Didactică şi Pedagogică, Bucureşti, 1995.69. Olinic N, Zdrenghea D: Cardiopatia ischemic ă, Editura Clusium, 1998;

    77 – 100.

    70. Pelouch V: Molecular aspects of regulation of cardiac contraction. Physiol Res, 1995; 44; 53 – 60.

    71. Pickering TG: Renovascular hypertension. Semin. Nucl. Med. 1989;19: 79 – 88.

    72. Preston RA, Singer I, Epstein M: Renal parenchimal hypertension. Arch. Intern. Med, 1996; 156: 602 – 611.

    73. Price A. David, Klenerman P., Booth L.B., Phillips E.R., Sewell K.A.

    Cytotoxic T lymphocytes, chemokines and antiviral immunity .Immunology Today, 1999; 20: 212 – 215.

    74. Puşcaş  I. Probleme actuale şi concepţ ii noi în patologia gastro-duodenal ă, Ed.Medicală, 1978

    75. Remuzzi G. et al.: Pathophysiology of progressive nephropathies. N.Engl. J. Med., 1998; 339; 20; 448-456.

    76. Repine EJ, Bast A, Lankhorst: Oxidative stress in chronic obstructive.  Am J Respir Crit Care Med, 1997; 156; 341 – 357.

    77. Roitt I, Brostoff J, Male D: Immunology , third edition, 1993.

    78. Ross R: Atherosclerosis an inflammatory disease, N Engl J Med, 1999;

    340, 115 – 126.79. Rozansski A, Blumenthal AJ, Kaplan J: Impact of psychological factors

    on the pathogenessis of cardiovascular disease and implications fortherapy. Circulation, 1999; 94, 2192 – 2217.

    80. Schiller A.: Insuficienţa renală acută. În Nefrologie clinică, sub red. Gh.Gluhovschi, Timişoara, ed. Helicon, 1997; 585-628.

    81. Sherlock S., Dosley J.: Diseases of the liver and biliary sistem. 10thEd. Blackwell Sc., 1997; 87-102.

  • 8/20/2019 Bibiografie finala

    9/9

     Bibliografie

    - 446 - 

    82. Sidebotham R.L, Baron J.H, Hollander F.: The two component mucousbarrier . Gastroenterology International, 1994; 5; 135 – 140.

    83. Stanciu C., Gastroenterologie practic ă, vol.I şi vol.II, Ed.Junimea,1979.

    84. Steer K.L. et al.: Chronic pancreatitis. N. Engl. J. Med., 1995; 332;1482-1496.

    85. Târcoveanu E.: Patologie chiurgical ă  – esofag, duoden, stomac. Ed.Dosoftei, Iaşi, 1995.

    86. Teodorescu Exarcu I. Fiziologia şi fiziopatologia digestiei, Ed.Medicală,

    Bucureşti, 1982.87. Tisher C., Craig W.: Nephrology & Hypertension, fourth edition,

    Lippincott, Williams & Wilkins, 1999.

    88. Tobian L: Salt and hypertension. Lessons from animal models thatrelate to human hypertension. Hypertension, 1991; 17 (supl I): 152 –158.

    89. Vîlcu Al.: ERITROCITUL, Ed. Med.Bucureşti, 1977.

    90. Volpe M, Tritto C, Testa U et al: Blood levels of erythropoietin incongestive heart failure and correlation with clinical, hemodynamic andhormonal profiles; Am J Cardiol, 1994; 74; 468 – 473.

    91. Wehling M, Spes C, Win N et al: Rapid cardiovascular action ofaldosterone in man. J Clin Endocr Metab, 1998; 83; 3517 – 22.

    92. Weinberger m MH, Fineberg NS: Sodium and volume sensitivity ofblood pressure. Age and pressure change over time. Hypertension,1991; 18: 67 – 71.

    93. Weinstein W.M.: Other types of gastritis and gastropathies includingMénétrier’s disease. In Feldman M. eds.: Sleisenger and Fordtran’sGastrointestinal and Liver Disease, 6th ed., London, 1998; 711-732.

    94. Yardley J.H.: Pathology of chronic gastritis and duodenitis. In GoldmanH. eds.: Gastrointestinal Pathology, Baltimore, 1996; 69-143.

    95. Zarifis J, Lip GY, Leatherdale B, Beevers G: Malignant hypertension in

    association with primary aldosteron. Blood Pressure, 1996; 5: 250 –254.